I think the boost for the RAP SP will be that the FDA acknowledge the current massive effort in Joondalup and other previous trials with adult patients show that the smart phone algorythims work and will be sufficient for their approval.
When that news arrives the SP can go north.
But the risk that adult trials do not , yet, work as accurately as the paediatric results should, keep all investors on point.
Definitely optimistic but also cautious at this stage.
Fox
Tencent's online hospital, page-9
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)